ADC Therapeutics (ADCT) Assets: 2019-2023
Historic Assets for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $466.9 million.
- ADC Therapeutics' Assets fell 12.20% to $466.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $466.9 million, marking a year-over-year decrease of 12.20%. This contributed to the annual value of $490.9 million for FY2022, which is 79330.62% up from last year.
- Per ADC Therapeutics' latest filing, its Assets stood at $466.9 million for Q3 2023, which was down 7.96% from $507.3 million recorded in Q2 2023.
- In the past 5 years, ADC Therapeutics' Assets registered a high of $638.0 million during Q3 2021, and its lowest value of $137,682 during Q4 2019.
- For the 3-year period, ADC Therapeutics' Assets averaged around $466.5 million, with its median value being $490.9 million (2022).
- In the last 5 years, ADC Therapeutics' Assets skyrocketed by 124,119.86% in 2021 and then dropped by 19.63% in 2023.
- Over the past 5 years, ADC Therapeutics' Assets (Quarterly) stood at $137,682 in 2019, then reached $521,526 in 2020, then spiked by 122,229.28% to $617,972 in 2021, then soared by 79,330.62% to $490.9 million in 2022, then fell by 12.20% to $466.9 million in 2023.
- Its Assets was $466.9 million in Q3 2023, compared to $507.3 million in Q2 2023 and $467.7 million in Q1 2023.